Ciprofloxacin and Dexamethasone

Product NDC
62332-776
Requested package NDC
62332-776-75
11-digit product format
623320776
Labeler code
62332
Product ID
62332-776_1672a69a-eeff-4e2c-b197-879de18c18dc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ciprofloxacin and Dexamethasone
Dosage form
SUSPENSION/ DROPS
Route
AURICULAR (OTIC)
Labeler
Alembic Pharmaceuticals Inc.
Application
ANDA217723
Marketing category
ANDA
Marketing start
2026-10-15
Substance
CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE
Active strength
3; 1 mg/mL; mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217723-001CIPROFLOXACIN AND DEXAMETHASONECIPROFLOXACIN; DEXAMETHASONE0.3%;0.1%SUSPENSION/DROPS / OTICAB2026-10-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A217723-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A217723-001CIPROFLOXACIN AND DEXAMETHASONE0.3%;0.1%SUSPENSION/DROPS / OTICAB2026-10-15d4dbc9d85df4…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A217723-001AB1d4dbc9d85df4…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Ciprofloxacin and Dexamethasone
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CIPROFLOXACIN HYDROCHLORIDE3 mg/mL
DEXAMETHASONE1 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4BA73M5E37Internal UNII lookup
7S5I7G3JQLInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
403908Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
79344381-dcfe-41bd-a997-5c303c81d4e1Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ciprofloxacin and DexamethasoneCIPROFLOXACIN AND DEXAMETHASONEAlembic Pharmaceuticals Inc.79344381-dcfe-41bd-a997-5c303c81d4e12026-10-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217723
application number: ANDA217723
ndc (package): 62332-776-75
ndc (product): 62332-776
ndc11 (package): 62332077675
Ciprofloxacin and DexamethasoneCIPROFLOXACIN AND DEXAMETHASONEAlembic Pharmaceuticals Limited5f69b7b6-6fb8-417a-bc0e-995419b952b72026-10-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217723
application number: ANDA217723

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
62332-776-75623320776751 BOTTLE in 1 CARTON (62332-776-75) / 7.5 mL in 1 BOTTLE1 bottle2026-10-15NoNoCurrent